Pro-atrial natriuretic peptide hormone from right atria is correlated with cardiac depression in septic patients

被引:18
作者
Mazul-Sunko, B
Zarkovic, N
Vrkic, N
Klinger, R
Peric, M
Bekavac-Beslin, M
Novkoski, M
Krizmanic, A
Gvozdenovic, A
Topic, E
机构
[1] Univ Hosp Sestre Milosrdnice, Dept Anesthesiol & Intens Care Med, HR-10000 Zagreb, Croatia
[2] Univ Hosp Sestre Milosrdnice, Dept Clin Chem, HR-10000 Zagreb, Croatia
[3] Univ Hosp Sestre Milosrdnice, Dept Surg, HR-10000 Zagreb, Croatia
[4] Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia
[5] Biomed Grp, Graz, Austria
关键词
ProANP(I-98); plasma; intensive care; sepsis; cardiac depression; ARDS;
D O I
10.1007/BF03343878
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
N-terminal pro-atrial natriuretic peptide [proANP(1-98)] has been extensively investigated in patients with chronic heart failure and ishemic heart disease. It is found to be a better marker of cardiac dysfunction than atrial natriuretic peptide (ANP). The possible involvement of proANP(1-98) in cardiac depression caused by sepsis has not been studied yet. Therefore, we analyzed atrial plasma concentration of proANP(1-98) in 17 septic patients with hemodynamic variables measured or calculated using pulmonary artery catheter, The results of altogether 96 measurements show a significant negative correlation of proANP(1-98) and cardiac index (p<0.024), oxygen delivery (p<0.03) and oxygen consumption (p<0.03), There is also a positive correlation with pulmonary vascular resistance (p<0.03). ProANP(1-98) is significantly higher in patients who developed acute respiratory distress syndrome (ARDS) (p<0.001), This study implies that proANP(1-98) is a possible novel hormone marker of cardiac depression caused by sepsis that could be used for prediction of ARDS. (J. Endocrinol. Invest, 24: RC22-RC24, 2001) (C) 2001, Editrice Kurtis.
引用
收藏
页码:RC22 / RC24
页数:3
相关论文
共 12 条
[1]   CONCENTRATIONS OF N-TERMINAL PROANP IN HUMAN PLASMA - EVIDENCE FOR PROANP (1-98) AS THE CIRCULATING FORM [J].
BUCKLEY, MG ;
SAGNELLA, GA ;
MARKANDU, ND ;
SINGER, DRJ ;
MACGREGOR, GA .
CLINICA CHIMICA ACTA, 1990, 191 (1-2) :1-14
[2]   A RAPID AND POTENT NATRIURETIC RESPONSE TO INTRAVENOUS-INJECTION OF ATRIAL MYOCARDIAL EXTRACT IN RATS [J].
DEBOLD, AJ ;
BORENSTEIN, HB ;
VERESS, AT ;
SONNENBERG, H .
LIFE SCIENCES, 1981, 28 (01) :89-94
[3]   Brain natriuretic peptide as bridge to therapy for heart failure [J].
Dries, DL ;
Stevenson, LW .
LANCET, 2000, 355 (9210) :1112-1113
[4]   Atrial natriuretic peptide release is more dependent on atrial filling volume than on filling pressure in chronic congestive heart failure [J].
Globits, S ;
Frank, H ;
Pacher, B ;
Huelsmann, M ;
Ogris, E ;
Pacher, R .
AMERICAN HEART JOURNAL, 1998, 135 (04) :592-597
[5]   α-Atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock [J].
Hartemink, KJ ;
Groeneveld, ABJ ;
de Groot, MCM ;
van Schijndel, RJMS ;
van Kamp, G ;
Thijs, LG .
CRITICAL CARE MEDICINE, 2001, 29 (01) :80-87
[6]   PLASMA N-TERMINAL ATRIAL-NATRIURETIC-PEPTIDE IN ACUTE MYOCARDIAL-INFARCTION [J].
KETTUNEN, RVJ ;
LEPPALUOTO, J ;
JOUNELA, A ;
VUOLTEENAHO, O .
AMERICAN HEART JOURNAL, 1994, 127 (06) :1449-1455
[7]  
Levin ER, 1998, NEW ENGL J MED, V339, P321
[8]   PLASMA ALPHA-ATRIAL NATRIURETIC PEPTIDE CONCENTRATIONS IN ACUTE RESPIRATORY-FAILURE ASSOCIATED WITH SEPSIS - PRELIMINARY-STUDY [J].
MITAKA, C ;
NAGURA, T ;
SAKANISHI, N ;
TSUNODA, Y ;
TOYOOKA, H .
CRITICAL CARE MEDICINE, 1990, 18 (11) :1201-1203
[9]   The gene encoding atrial natriuretic peptide and the risk of human stroke [J].
Rubattu, S ;
Ridker, P ;
Stampfer, MJ ;
Volpe, M ;
Hennekens, CH ;
Lindpaintner, K .
CIRCULATION, 1999, 100 (16) :1722-1726
[10]   Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction [J].
Uusimaa, P ;
Ruskoaho, H ;
Vuolteenaho, O ;
Niemelä, M ;
Lumme, J ;
Ikäheimo, M ;
Jounela, A ;
Peuhkurinen, K .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 69 (01) :5-14